Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
Antimicrobial Proteins01:23

Antimicrobial Proteins

10.6K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
10.6K
Antibiotic Selection00:57

Antibiotic Selection

48.9K
Overview
48.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mining the code of life for new antibiotics.

Cell host & microbe·2026
Same author

Discovery of novel antimicrobials within microbiomes.

Current opinion in microbiology·2026
Same author

Deep learning reveals antimicrobial peptides within prions.

Nature microbiology·2026
Same author

Correction: Molecular response to the non-lytic peptide bac7 (1-35) triggers disruption of Klebsiella pneumoniae biofilm.

PLoS pathogens·2026
Same author

A generative artificial intelligence approach for peptide antibiotic optimization.

Nature machine intelligence·2026
Same author

Synthetic peptides targeting a mast cell-specific G protein-coupled receptor MRGPRB2 display anti-infective potential.

Cell biomaterials·2026

Related Experiment Video

Updated: May 1, 2026

Production and Testing of Antimicrobial Peptides and Their Mimics
10:32

Production and Testing of Antimicrobial Peptides and Their Mimics

Published on: April 10, 2026

424

From generation to validation: Deep generative models for antimicrobial peptide discovery.

Zehua Sun1, Xiaoyu Wang2, Shibo Kuang3

  • 1Process Technology Laboratory, Department of Chemical and Biological Engineering, Monash University, Clayton, VIC 3800, Australia; ARC-Research Hub for Smart Process Design and Control, Department of Chemical and Biological Engineering, Monash University, Clayton, VIC, 3800, Australia; Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Melbourne, VIC 3800, Australia.

Current Opinion in Chemical Biology
|April 29, 2026
PubMed
Summary
This summary is machine-generated.

Artificial intelligence (AI) accelerates the discovery of antimicrobial peptides (AMPs) as alternatives to antibiotics. Generative models show promise but require better data, validation, and control for clinical translation.

More Related Videos

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
11:56

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids

Published on: May 4, 2018

13.1K
Author Spotlight: Characterizing Airway Environments to Advance Model Systems and Antimicrobial Discovery in Cystic Fibrosis and Chronic Respiratory Infections
06:19

Author Spotlight: Characterizing Airway Environments to Advance Model Systems and Antimicrobial Discovery in Cystic Fibrosis and Chronic Respiratory Infections

Published on: October 11, 2024

3.2K

Related Experiment Videos

Last Updated: May 1, 2026

Production and Testing of Antimicrobial Peptides and Their Mimics
10:32

Production and Testing of Antimicrobial Peptides and Their Mimics

Published on: April 10, 2026

424
Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
11:56

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids

Published on: May 4, 2018

13.1K
Author Spotlight: Characterizing Airway Environments to Advance Model Systems and Antimicrobial Discovery in Cystic Fibrosis and Chronic Respiratory Infections
06:19

Author Spotlight: Characterizing Airway Environments to Advance Model Systems and Antimicrobial Discovery in Cystic Fibrosis and Chronic Respiratory Infections

Published on: October 11, 2024

3.2K

Area of Science:

  • Biochemistry and Molecular Biology
  • Computational Biology and Bioinformatics
  • Drug Discovery and Development

Background:

  • Antibiotic resistance is a growing global health threat, necessitating novel therapeutic strategies.
  • Antimicrobial peptides (AMPs) show potential as alternatives to conventional antibiotics due to their effectiveness against resistant pathogens.
  • Traditional methods for identifying new AMP candidates are slow and resource-intensive.

Purpose of the Study:

  • To review recent advancements in artificial intelligence (AI)-driven generative models for antimicrobial peptide (AMP) discovery.
  • To compare various generative modeling strategies, including VAEs, GANs, and diffusion models.
  • To outline validation methods for assessing AMP efficacy and safety.

Main Methods:

  • Review of current literature on AI-based generative models for AMP design.
  • Systematic comparison of different modeling approaches (VAEs, GANs, diffusion models).
  • Analysis of validation techniques for peptide activity and toxicity.

Main Results:

  • Generative AI models, including VAEs, GANs, and diffusion models, enable de novo design of AMPs with potent activity and reduced toxicity.
  • Significant challenges persist, including dataset quality, prediction calibration, controllable generation, and reproducible validation.
  • The review provides insights into peptide-centered generative modeling and its limitations.

Conclusions:

  • AI-powered generative models offer a powerful approach to accelerate AMP discovery, addressing the limitations of traditional methods.
  • Addressing challenges in data, prediction, control, and validation is crucial for clinical translation of AI-designed AMPs.
  • Future directions involve developing more robust and clinically relevant AMP generation models.